ALBA THERAPEUTICS
Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba’s technology is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, asthma/COPD and acute lung injury.
ALBA THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2004-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.albatherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(443) 682-2535
Email Addresses:
[email protected]
Total Funding:
30 M USD
Technology used in webpage:
British Virgin Island Server Location
Similar Organizations
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
DNA Therapeutics
DNA Therapeutics, a privately-held, clinical-stage biopharmaceutical company.
Vitrisa Therapeutics
Vitrisa Therapeutics is a privately held, preclinical stage, biotech company headquartered in the San Francisco Bay Area.
Current Advisors List
Current Employees Featured
Founder
Investors List
HealthCap
HealthCap investment in Series A - Alba Therapeutics
Alta Partners
Alta Partners investment in Series A - Alba Therapeutics
SV Health Investors
SV Health Investors investment in Series A - Alba Therapeutics
Red Abbey Venture Partners
Red Abbey Venture Partners investment in Series A - Alba Therapeutics
Maryland Venture Fund
Maryland Venture Fund investment in Series A - Alba Therapeutics
Official Site Inspections
http://www.albatherapeutics.com
- Host name: 204.11.56.41
- IP address: 204.11.56.41
- Location: British Virgin Islands
- Latitude: 18.5
- Longitude: -64.5
- Timezone: America/Tortola
More informations about "Alba Therapeutics"
Home - Alia Therapeutics
Alia Therapeutics is a pioneering gene editing company with a vision to revolutionize medicine by curing genetic diseases at their roots.;See details»
Alia Therapeutics - Crunchbase Company Profile
Next-generation gene editing medicines: Alia Therapeutics is focused on developing gene editing treatments aimed at curing rare genetic diseases by directly correcting genetic errors in patient cells.See details»
Alba Therapeutics - Crunchbase Company Profile & Funding
Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to …See details»
Alia Therapeutics - LinkedIn
Alia Therapeutics is a pioneering gene editing company with a vision to revolutionize medicine by curing genetic diseases at their roots. Alia’s versatile portfolio of novel CRISPR systems ...See details»
Board of Directors - Alia Therapeutics
Letizia Goretti CEO and Member of the Board Letizia joins from Johnson & Johnson and has over 25 years of international life science industry experience. Letizia brings a broad background in …See details»
Alia Therapeutics names Letizia Goretti as Chief Executive Officer
MILAN, May 5, 2023 — Alia Therapeutics, a Trento-based start-up specializing in innovative treatments for rare genetic diseases through next-generation gene editing technology, …See details»
Alia Therapeutics - PitchBook
Alia Therapeutics General Information Description. Developer of gene editing technology designed to treat genetic diseases at their roots. The company offers a portfolio of advanced …See details»
Alia People - Alia Therapeutics
Letizia Goretti. CEO. Letizia joins from Johnson & Johnson and has over 25 years of international life science industry experience. Letizia brings a broad background in strategic, operational, …See details»
Alia Therapeutics — Sofinnova Partners
Www.aliatherapeutics.com. Paola Pozzi. Partner, Sofinnova Partners - Telethon Strategy. Related News. 9 May, 2023 Alia Therapeutics appoints Adel Nada as Independent Board Director; 4 …See details»
Alia Therapeutics names Letizia Goretti as Chief Executive Officer
May 5, 2023 Alia Therapeutics , Friday, May 5, 2023, Press release picture. Letizia, who is joining Alia from Johnson & Johnson, has more than 25 years of international experience in life …See details»
Alia Therapeutics - INDACO
Www.aliatherapeutics.com. Investment Status. Ongoing. Alia Therapeutics is an Italian biotech start-up developing innovative treatments for incurable genetic diseases based on gene …See details»
Alba Therapeutics - PitchBook
Alba Therapeutics General Information Description. Developer of therapeutics to treat autoimmune, immune mediated and inflammatory diseases. The company's Permeability …See details»
Alia Therapeutics - Funding, Financials, Valuation & Investors
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.See details»
Alia Therapeutics - Products, Competitors, Financials, Employees ...
Read more at aliatherapeutics.com About Sofinnova Partners Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. …See details»
Alia Therapeutics appoints Adel Nada as Independent Board Director
MILAN, May 9, 2023 — Alia Therapeutics, a Trento-based start-up specializing in innovative treatments for rare genetic diseases through next-generation gene editing technology, …See details»
Alia Therapeutics - VentureRadar
Similar Companies: Website: https://www.aliatherapeutics.com/ Alia Therapeutics Srl is an Italian biotech start-up whose mission is to develop innovative treatments ...See details»
Technology - Alia Therapeutics
Alia stems out of pioneering research of Professor Anna Cereseto and Doctor Antonio Casini at Trento University. Our thesis: The diversity and complexity of human genetic diseases …See details»
Alia Therapeutics - Trentino Innovation
Alia Therapeutics, the first Italian CRISPR-company, is developing innovative therapeutic approaches to defeat previously incurable genetic diseases.See details»
Alia Therapeutics secures €4.4 million seed financing ... - Sofinnova
MILAN, April 17, 2023 – Alia Therapeutics, a Trento-based start-up specializing in innovative treatments for rare genetic diseases through next-generation gene editing technology, has …See details»
First Licensed Celiac Treatment Heads to Phase 3 Trials
A drug to treat celiac disease could very well be just around the corner. Alba Therapeutics is on the FDA fast track, and we're here to share with you all of the details of this exciting …See details»